The Pharmacy Times® HIV Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of HIV, a virus that attacks the body's immune system and, if left untreated, can lead to AIDS.
October 28th 2024
Islatravir in combination with lenacapavir could become the first weekly oral HIV treatment.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pharmacist Services to Populations at Risk for HIV: Improving Access and Uptake of Preexposure Prophylaxis
1.0 Credit / HIV/AIDS
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
Treatment Decision-Making for Complex Patients With HIV: Drug Resistance, Adverse Effects, Comorbidities and P...
1.5 Credits / HIV/AIDS
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Study Suggests Second Patient Cured from HIV Through Stem Cell Transplantation
March 23rd 2020A study of the second HIV patient to undergo successful stem cell transplantation from donors with an HIV-resistant gene found that there was no active viral infection in the patient’s blood 30 months after they stopped antiretroviral therapy.
Read More
Study: Visceral Fat is Predictor of Liver Fibrosis, Fibrosis Progression in People With HIV
March 20th 2020The findings highlight the critical role played by excess visceral adiposity in the progression of fibrosis among HIV-infected patients with nonalcoholic fatty liver disease, according to the study authors.
Read More
Penalties for HIV Exposure Reduced in State of Washington
March 5th 2020In addition, the new legislation calls for more intervention from local and state health officers, allowing them to recommend options ranging from testing to counseling. This includes the ability to mandate treatment for an individual determined to be placing others at risk.
Read More
New Genes Controlling HIV Infection Discovered That Could Help Make Predictions About Pharmacy
March 4th 2020Scientists at the Gladstone Institutes have cataloged host proteins that physically bind to HIV proteins, which identify human proteins that the virus can use to infect cells and spread.
Read More
Colorado Aims to Let Pharmacists Write Own Prescriptions for HIV Prevention Drugs
March 3rd 2020The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."
Read More
U=U Continues to Unite HIV Community, Dismantle Stigma Around the Epidemic
March 3rd 2020The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.
Read More
Dolutegravir Is Susceptible to Chelation-Type Interactions
Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.
Read More
New Integrated HIV Curriculum Lays the Foundation for Future Pharmacy Students
February 15th 2020The scope of HIV/AIDS treatment in America has changed immensely in recent years across the pharmacy landscape. Roosevelt University's College of Pharmacy (RUCOP) is helping to highlight this shift in its updated HIV/AIDS care and training program.
Read More
HIV Attacks Young Brain, Even with Early Treatment
January 10th 2020Recent studies have shown that the HIV virus may affect the brains of children living with and exposed to the virus, even with early antiretroviral therapy (ART). HIV can disrupt neurodevelopment, which affects how children learn, reason, and function.
Read More
Assessment Shows Potential Need for More Preventive Cardiovascular Care in Patients with HIV
December 21st 2019There is a statistically significant difference in the number of patients that meet statin criteria for primary prevention, and those that were prescribed it in a Federally Qualified Health Center (FQHC), according to student research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.
Read More
Mental Health Watch: Cognitive Impairment Is Linked to Presence of Persistent HIV in CNS
December 20th 2019Many individuals with HIV who are receiving antiretroviral therapy have viral genetic material in the cells of their cerebrospinal fluid, making them more likely to experience memory and concentration problems, according to the results of a new study.
Read More